| Category | Min Lots | Shares | Amount |
|---|---|---|---|
| Retail (sNII) | 1 | 24 | ₹14,640 |
| HNI / NII | 14 | 336 | ₹2,04,960 |
| bHNI / bNII | 69 | 1,656 | ₹10,10,160 |
| Category | Sub (×) | Offered | Bid For | Amt (Cr)* |
|---|---|---|---|---|
| QIB | — | 46,69,143 (50.00%) | — | ₹28,481.78 Cr |
| NII / HNI (Total) | — | 14,00,744 (15.00%) | — | ₹8,544.54 Cr |
| Retail Investors | — | 32,68,401 (35.00%) | — | ₹19,937.25 Cr |
| Total ** | — | 93,38,288 (100.00%) | — | ₹569,635.57 Cr |
| Metric | 31-Mar-21 | 31-Mar-20 | 31-Mar-19 |
|---|---|---|---|
| Revenue | 341.99 | 242.49 | 238.90 |
| PAT | 54.00 | 27.47 | 23.30 |
| EBITDA | — | — | — |
| Net Worth | — | — | — |
| Total Assets | 413.27 | 231.89 | 213.15 |
| Reserves | — | — | — |
| Borrowings | — | — | — |
Incorporated in 2004, Ami Organics Limited is one of the leading research and development driven manufacturers of specialty chemicals. The company manufactures different types of Advanced Pharmaceutical Intermediates and Active Pharmaceutical ingredients (API) for New Chemical Entities, and material for agrochemicals and fine chemicals.
The company has developed over 450 pharma intermediates across 17 key therapeutic areas i.e. anti-retroviral, anti-inflammatory, anti-psychotic, anti-cancer, anti-Parkinson, anti-depressant, and anti-coagulant. It supplies its products to more than 150 customers (including international customers) directly in India and in 25 countries overseas i.e. Europe, USA, China, Israel, Japan, Latin America, etc. Laurus Labs, Cadila Healthcare, Cipla Ltd are some of the domestic customers whereas Organike s.r.l.a. Socio Unico, Fermion Oly, Medichem S.A. and Midas Pharma GmbH are some of the international customers.
The company has three manufacturing facilities in Gujarat situated at Sachin, Ankleshwar & Jhagadia, with an aggregate installed capacity of 6,060 MTPA.
Competitive strengths: